10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects

NCT00139581 ·Status: COMPLETED ·Phase: PHASE4

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

NCT00510003 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

NCT00150059 ·Status: COMPLETED ·Phase: PHASE4

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

NCT00925730 ·Status: COMPLETED ·Phase: PHASE4

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

NCT00666159 ·Status: COMPLETED ·Phase: PHASE4

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

NCT00509990 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus and Epidermal Barrier Function

NCT01132079 ·Status: COMPLETED ·Phase: NA

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

NCT00117377 ·Status: COMPLETED ·Phase: PHASE4

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

NCT00667160 ·Status: COMPLETED ·Phase: PHASE4

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

NCT00351052 ·Status: COMPLETED ·Phase: PHASE3

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

NCT04976868 ·Status: COMPLETED

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

NCT00484003 ·Status: COMPLETED ·Phase: PHASE4

Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis

NCT01202149 ·Status: COMPLETED ·Phase: PHASE4

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

NCT00810862 ·Status: TERMINATED ·Phase: PHASE4

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

NCT00121316 ·Status: COMPLETED ·Phase: PHASE4

A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis

NCT00403559 ·Status: COMPLETED ·Phase: PHASE2

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

NCT00379678 ·Status: COMPLETED

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

NCT03107611 ·Status: COMPLETED ·Phase: PHASE3

Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis

NCT00226707 ·Status: COMPLETED ·Phase: PHASE3

Combination Therapy for Atopic Dermatitis

NCT00119158 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

NCT05729074 ·Status: UNKNOWN ·Phase: PHASE1

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

NCT02896101 ·Status: COMPLETED ·Phase: PHASE3

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

NCT02791308 ·Status: COMPLETED ·Phase: PHASE3

Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

NCT00535691 ·Status: COMPLETED ·Phase: PHASE2

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

NCT03356977 ·Status: COMPLETED ·Phase: PHASE4